We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+11.4%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$361M
AUM Growth
+$13.5M
Cap. Flow
+$2.7M
Cap. Flow %
0.75%
Top 10 Hldgs %
38.32%
Holding
92
New
22
Increased
23
Reduced
17
Closed
21

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$12.1M
2
CNC icon
Centene
CNC
+$9.16M
3
BIIB icon
Biogen
BIIB
+$9M
4
ABT icon
Abbott
ABT
+$8.96M
5
AMED
Amedisys
AMED
+$8.04M

Top Sells

Rank Stock Value
1
ARNA
Arena Pharmaceuticals Inc
ARNA
+$17.9M
2
MDT icon
Medtronic
MDT
+$10M
3
HOLX
Hologic
HOLX
+$8.86M
4
ZBH icon
Zimmer Biomet
ZBH
+$8.78M
5
ACHC icon
Acadia Healthcare
ACHC
+$8.05M

Sector Composition

Rank Sector Weight
1 Healthcare 97.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HOLX
76
DELISTED
Hologic
HOLX
– –
-120,000
Closed -$8.86M
INSP icon
77
Inspire Medical Systems
INSP
$1.71B
– –
-10,000
Closed -$2.33M
LFST icon
78
Lifestance Health
LFST
$4.39B
– –
-350,000
Closed -$5.08M
MDT icon
79
Medtronic
MDT
$116B
– –
-80,000
Closed -$10M
NTRA icon
80
Natera
NTRA
$45.1B
– –
-40,000
Closed -$4.46M
PTGX icon
81
Protagonist Therapeutics
PTGX
$9.6B
– –
-35,000
Closed -$620K
REGN icon
82
Regeneron Pharmaceuticals
REGN
$82.1B
– –
-10,000
Closed -$6.05M
UHS icon
83
Universal Health Services
UHS
$9.94B
– –
-30,000
Closed -$4.15M
ZBH icon
84
Zimmer Biomet
ZBH
$18.5B
– –
-61,800
Closed -$8.78M
ZYME icon
85
Zymeworks
ZYME
$1.73B
– –
-50,000
Closed -$1.45M
RVNC
86
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-50,000
Closed -$1.39M
MRTX
87
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-20,000
Closed -$3.54M
SGEN
88
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-40,000
Closed -$6.79M
AERI
89
DELISTED
Aerie Pharmaceuticals
AERI
– –
-250,000
Closed -$2.85M
ZY
90
DELISTED
Zymergen Inc. Common Stock
ZY
– –
-160,000
Closed -$2.11M
ARNA
91
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-300,000
Closed -$17.9M
BHVN
92
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-20,000
Closed -$2.78M
1 2 3
4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Integral Health Asset Management held 92 positions worth $361M, up 3.9% from $348M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Integral Health Asset Management's Q4 2021 filing shows 22 new, 23 increased, 17 reduced and 21 closed positions. Its largest new stake was McKesson: 55,000 shares worth $13.7M. The largest sale was Arena Pharmaceuticals Inc, an estimated $17.9M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, down from 98% a quarter earlier.

  • Integral Health Asset Management's largest Q4 2021 buy was McKesson: 55,000 shares worth $13.7M.
  • Integral Health Asset Management added most to Centene in Q4 2021, an estimated $9.16M increase.
  • Integral Health Asset Management's biggest Q4 2021 reduction was Acadia Healthcare, cutting an estimated $8.05M.
  • Integral Health Asset Management fully exited Arena Pharmaceuticals Inc in Q4 2021, selling an estimated $17.9M.
  • Integral Health Asset Management's ten largest holdings make up 38% of its $361M portfolio in Q4 2021.
  • Integral Health Asset Management opened 22 new positions and closed 21 in Q4 2021.
  • Integral Health Asset Management's portfolio value rose 3.9% quarter-over-quarter to $361M.

Based on Integral Health Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.